Improving outcomes in patients with resectable pancreatic cancer
نویسندگان
چکیده
منابع مشابه
Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer.
BACKGROUND In the recent International Study Group of Pancreatic Surgery (ISGPS) consensus on extended pancreatectomy, several issues on perioperative outcome and long-term survival remained unclear. Robust data on outcomes are sparse. The present study aimed to assess the outcome of extended pancreatectomy for borderline resectable and locally advanced pancreatic cancer. METHODS A consecutiv...
متن کاملRole of radiation therapy in patients with resectable pancreatic cancer.
The 5-year overall survival of patients with pancreatic cancer is approximately 5%, with potentially resectable disease representing the curable minority. Although surgical resection remains the cornerstone of treatment, local and distant failure rates are high after complete resection, and debate continues as to the appropriate adjuvant therapy. Many oncologists advocate for adjuvant chemother...
متن کاملBorderline resectable pancreatic cancer.
Rigorous criteria to define "borderline resectable" pancreatic cancer are required for appropriate patient accrual into clinical trials that examine the utility of chemotherapy and/or chemoradiation that will be delivered prior to pancreatic resection for exocrine cancer. At our institution, tumor abutment of less than or equal to 180 degrees (< or = 50% of the vessel circumference) of the supe...
متن کاملPrognostic factors in resectable pancreatic cancer.
The pancreatic cancer is a disease with exponentially increased incidence, especially over the last decades, being the sixth or even fifth cause of death by cancer in most of the modern societies. Moreover, it is estimated that almost 95% of the patients with this disease are presenting to the doctor in the advanced and unresectable stages. Also, over the past few decades the development and ad...
متن کاملPreoperative Biliary Drainage in Resectable Pancreatic Cancer
Pancreatoduodenectomy (PD) offers the only option for cure in resectable, nonmetastatic pancreatic and periampullary cancer [1]. However, PD is technically challenging and fraught with a significant risk of morbidity and even mortality [2]. Obstructive jaundice is one of the most common symptoms of pancreatic and periampullary cancer [3]. Hyperbilirubinaemia has been recognised as contributory ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Surgery
سال: 2017
ISSN: 0007-1323,1365-2168
DOI: 10.1002/bjs.10692